Arrhythmogenic right ventricular cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC), formerly known as arrhythmogenic right ventricular dysplasia (ARVD), is now denoted as ARVD/C. It is characterized by progressive replacement of the right ventricular myocardium with fibrofatty tissue, and clinical manifestations include right ventricular enlargement, arrhythmias, and sudden death.
-
Site of disease:
heart -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Right heart failure systemic congestion cough syncope tachycardia myocardial hibernation phenomenon -
Concurrent disease:
Related Drugs
Sotalol Hydrochloride Tablets
Indication: 1 Cardioversion, prevention of supraventricular tachycardia, especially atrioventricular nodal reentrant tachycardia. It can also be used for preexcitation syndrome with supraventricular tachycardia. 2 Atrial flutter, atrial fibrillation. 3 Various ventricular arrhythmias, including ventricular premature beats, sustained and non-sustained ventricular tachycardia. 4 Acute myocardial infarction complicated by severe arrhythmias.
Manufacturer:
Xi`an Han Feng Pharmaceutical Co., Ltd.
Verapamil Hydrochloride Injection
Indication: 1. Cardioversion of rapid paroxysmal supraventricular tachycardia. Vagus nerve inhibition (such as Valsalva method) should be the first choice before applying verapamil. 2. Temporary control of ventricular rate in atrial flutter or atrial fibrillation. Except when atrial flutter or atrial fibrillation is combined with atrioventricular bypass pathway (preexcitation syndrome and LGL syndrome).
Manufacturer:
Yaopharma Co., Ltd.
Related Ingredients